Synthesis of 3-(4-(pyridin-2-yldiazenyl)phenoxy)propan-1-ol (compound 2) The 3-(4-(pyridin-2-yldiazenyl)phenoxy)propan-1-ol was synthetized using a similar procedure as previously reported 46
These products mainly support surface-level skin brightening
A search on PubMed returns many papers on rodents and cell models, and reviews on PubMed Central describe it as a possible therapy rather than a proven one
Mast cell activation leads to the release of specific inflammatory mediators such as TNF-, IL-1, IL-8, IL-33, chemokine (C-C motif) ligand 2 (CCL2), CCL3, CCL5, granulocyte macrophage colony-stimulating factor (GM-CSF), VEGF, matrix metalloproteinase (MMPs), ROS, substance P (SP), stem cell factor (SCF), nerve growth factor (NGF), dopamine, transforming growth factor-beta (TGF-), corticotrophin-releasing hormone (CRH), neurotensin, histamine, prostaglandin D2 (PGD2), leukotrienes (LTs), proteases tryptase and chymase based upon the type of mast cells and type of stimuli in the tissues (Gilfillan et al., 2011
Sample Diluent can be stored at 4 C for one month
